[HTML][HTML] Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
GBD 2016 Stroke Collaborators - The Lancet. Neurology, 2019 - ncbi.nlm.nih.gov
Background Stroke is a leading cause of mortality and disability worldwide and the
economic costs of treatment and post-stroke care are substantial. The Global Burden of …
economic costs of treatment and post-stroke care are substantial. The Global Burden of …
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study
Background Accurate diagnosis and early detection of complex diseases, such as
Parkinson's disease, has the potential to be of great benefit for researchers and clinical …
Parkinson's disease, has the potential to be of great benefit for researchers and clinical …
[HTML][HTML] Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning
KA Severson, LM Chahine, LA Smolensky… - The Lancet Digital …, 2021 - thelancet.com
Background Parkinson's disease is heterogeneous in symptom presentation and
progression. Increased understanding of both aspects can enable better patient …
progression. Increased understanding of both aspects can enable better patient …
Burden of neurological disorders across the US from 1990-2017: a global burden of disease study
Importance Accurate and up-to-date estimates on incidence, prevalence, mortality, and
disability-adjusted life-years (burden) of neurological disorders are the backbone of …
disability-adjusted life-years (burden) of neurological disorders are the backbone of …
The global burden of neurologic diseases
JH Chin, N Vora - Neurology, 2014 - AAN Enterprises
WHO categorizes causes of death and disability into (1) communicable diseases, maternal
and perinatal conditions, and nutritional deficiencies;(2) non-communicable diseases …
and perinatal conditions, and nutritional deficiencies;(2) non-communicable diseases …
The global burden of neurological disorders: translating evidence into policy
Neurological disorders are the leading cause of disability and the second leading cause of
death worldwide. In the past 30 years, the absolute numbers of deaths and people with …
death worldwide. In the past 30 years, the absolute numbers of deaths and people with …
[HTML][HTML] The global burden of motor neuron disease: an analysis of the 2019 global burden of disease study
J Park, JE Kim, TJ Song - Frontiers in Neurology, 2022 - frontiersin.org
Up-to-date, accurate information on the disease burden of motor neuron disease (MND) is
the cornerstone for evidence-based resource allocation and healthcare planning. We aimed …
the cornerstone for evidence-based resource allocation and healthcare planning. We aimed …
[HTML][HTML] Incidence of Parkinson disease in North America
Parkinson disease (PD) is the second most common age-related neurodegenerative
condition diagnosed in North America. We recently demonstrated, using multiple …
condition diagnosed in North America. We recently demonstrated, using multiple …
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study
A Schrag, UF Siddiqui, Z Anastasiou… - The Lancet …, 2017 - thelancet.com
Background Parkinson's disease is associated with an increased incidence of cognitive
impairment and dementia. Predicting who is at risk of cognitive decline early in the disease …
impairment and dementia. Predicting who is at risk of cognitive decline early in the disease …
Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and …
JC Latourelle, MT Beste, TC Hadzi, RE Miller… - The Lancet …, 2017 - thelancet.com
Background Better understanding and prediction of progression of Parkinson's disease
could improve disease management and clinical trial design. We aimed to use longitudinal …
could improve disease management and clinical trial design. We aimed to use longitudinal …